Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa

Annals of Laboratory Medicine - Tập 34 Số 4 - Trang 286-292 - 2014
Hye Hyun Cho1, Kye Chul Kwon2, Semi Kim2, Sun Hoe Koo2
1Department of Biomedical Laboratory Science, Jeonju Kijeon College, Jeonju, Korea.
2Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Shaver, 2004, Infect Immun, 72, 6969, 10.1128/IAI.72.12.6969-6977.2004

Galán, 1999, Science, 284, 1322, 10.1126/science.284.5418.1322

Wong-Beringer, 2008, Clin Microbiol Infect, 14, 330, 10.1111/j.1469-0691.2007.01939.x

Veesenmeyer, 2009, Crit Care Med, 37, 1777, 10.1097/CCM.0b013e31819ff137

Frank, 1997, Mol Microbiol, 26, 621, 10.1046/j.1365-2958.1997.6251991.x

Sato, 2004, Mol Microbiol, 53, 1279, 10.1111/j.1365-2958.2004.04194.x

Feltman, 2001, Microbiology, 147, 2659, 10.1099/00221287-147-10-2659

Fleiszig, 1997, Infect Immun, 65, 579, 10.1128/IAI.65.2.579-586.1997

Roy-Burman, 2001, J Infect Dis, 183, 1767, 10.1086/320737

Schulert, 2003, J Infect Dis, 188, 1695, 10.1086/379372

El Solh, 2008, Am J Respir Crit Care Med, 178, 513, 10.1164/rccm.200802-239OC

Thomson, 1999, J Antimicrob Chemother, 43, 31, 10.1093/jac/43.suppl_1.31

Karlowsky, 2003, Antimicrob Agents Chemother, 47, 1681, 10.1128/AAC.47.5.1681-1688.2003

Lee, 2003, Yonsei Med J, 44, 571, 10.3349/ymj.2003.44.4.571

Lee, 2004, J Korean Med Sci, 19, 8, 10.3346/jkms.2004.19.1.8

Lee, 2012, Int J Antimicrob Agents, 40, 168, 10.1016/j.ijantimicag.2012.04.004

Ruiz, 2003, J Antimicrob Chemother, 51, 1109, 10.1093/jac/dkg222

Valdezate, 2002, Antimicrob Agents Chemother, 46, 665, 10.1128/AAC.46.3.665-671.2002

Mouneimné, 1999, Antimicrob Agents Chemother, 43, 62, 10.1128/AAC.43.1.62

Vila, 1997, J Antimicrob Chemother, 39, 757, 10.1093/jac/39.6.757

Sáenz, 2003, J Antimicrob Chemother, 51, 1001, 10.1093/jac/dkg168

Clinical and Laboratory Standards Institute, 2010, Performance standards for antimicrobial susceptibility testing: Twentieth Informational supplement, M100-S20

Agnello, 2012, PLoS One, 7, e42973, 10.1371/journal.pone.0042973

Lee, 2005, Int J Antimicrob Agents, 25, 290, 10.1016/j.ijantimicag.2004.11.012

Gasink, 2006, Am J Med, 119, 526.e19, 10.1016/j.amjmed.2005.11.029

Jalal, 2000, Antimicrob Agents Chemother, 44, 710, 10.1128/AAC.44.3.710-712.2000

Holder, 2001, Burns, 27, 129, 10.1016/S0305-4179(00)00142-X

Kulasekara, 2006, J Bacteriol, 188, 4037, 10.1128/JB.02000-05

Hauser, 2002, Crit Care Med, 30, 521, 10.1097/00003246-200203000-00005

Hsu, 2005, J Antimicrob Chemother, 55, 535, 10.1093/jac/dki026

Cho, 2013, Ann Clin Lab Sci, 43, 414

Lee, 2013, J Med Microbiol, 62, 1015, 10.1099/jmm.0.055426-0

Matsumoto, 2012, Int J Antimicrob Agents, 40, 440, 10.1016/j.ijantimicag.2012.06.021

Hrabák, 2011, J Clin Microbiol, 49, 474, 10.1128/JCM.00684-10

Nakano, 1997, Antimicrob Agents Chemother, 41, 2289, 10.1128/AAC.41.10.2289

Higgins, 2003, Int J Antimicrob Agents, 21, 409, 10.1016/S0924-8579(03)00009-8

Akasaka, 2001, Antimicrob Agents Chemother, 45, 2263, 10.1128/AAC.45.8.2263-2268.2001

Oh, 2003, Microb Drug Resist, 9, 323, 10.1089/107662903322762743

Shultz, 2001, Antimicrob Agents Chemother, 45, 734, 10.1128/AAC.45.3.734-738.2001

Parry, 2010, Antimicrob Agents Chemother, 54, 5201, 10.1128/AAC.00963-10